Tom Pembroke

542 total citations
24 papers, 408 citations indexed

About

Tom Pembroke is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Tom Pembroke has authored 24 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 13 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Tom Pembroke's work include Liver Disease Diagnosis and Treatment (13 papers), Immune Cell Function and Interaction (8 papers) and Liver Disease and Transplantation (7 papers). Tom Pembroke is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Immune Cell Function and Interaction (8 papers) and Liver Disease and Transplantation (7 papers). Tom Pembroke collaborates with scholars based in United Kingdom, Canada and Italy. Tom Pembroke's co-authors include Awen Gallimore, Andrew Godkin, Robert K. Hills, Kathryn Smart, Hayley Bridgeman, Anja Bloom, Martin Scurr, Amanda Thomson, Sarah Gwynne and A. Brewster and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Gut.

In The Last Decade

Tom Pembroke

19 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Pembroke United Kingdom 10 177 137 129 120 50 24 408
Kiran Dhanireddy United States 11 89 0.5× 75 0.5× 87 0.7× 64 0.5× 38 0.8× 29 420
Sujit Mukherjee United Kingdom 8 110 0.6× 162 1.2× 166 1.3× 173 1.4× 54 1.1× 10 480
Àngels Vilella Spain 11 74 0.4× 227 1.7× 99 0.8× 143 1.2× 36 0.7× 27 577
Maki Oiwa‐Monna Japan 11 134 0.8× 48 0.4× 134 1.0× 11 0.1× 38 0.8× 31 519
Tarek Besheer Egypt 13 48 0.3× 215 1.6× 46 0.4× 183 1.5× 52 1.0× 35 405
Ingolf Mølle Denmark 9 62 0.4× 75 0.5× 30 0.2× 27 0.2× 21 0.4× 21 246
Giambattista Lobreglio Italy 12 105 0.6× 94 0.7× 47 0.4× 28 0.2× 23 0.5× 32 370
S M Devine United States 9 31 0.2× 99 0.7× 119 0.9× 66 0.6× 62 1.2× 12 517
Irena Brabcová Czechia 13 120 0.7× 64 0.5× 77 0.6× 33 0.3× 56 1.1× 20 434
Xinan Wan Australia 8 49 0.3× 123 0.9× 249 1.9× 37 0.3× 53 1.1× 12 434

Countries citing papers authored by Tom Pembroke

Since Specialization
Citations

This map shows the geographic impact of Tom Pembroke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Pembroke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Pembroke more than expected).

Fields of papers citing papers by Tom Pembroke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Pembroke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Pembroke. The network helps show where Tom Pembroke may publish in the future.

Co-authorship network of co-authors of Tom Pembroke

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Pembroke. A scholar is included among the top collaborators of Tom Pembroke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Pembroke. Tom Pembroke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fenn, G C, et al.. (2025). The role of C3 in steatotic liver disease. Immunobiology. 230(4). 153027–153027.
2.
Lebouché, Bertrand, Jean‐Pierre Routy, Marina B. Klein, et al.. (2025). Distinct Gut Microbiota Signatures Are Associated with Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease in People with HIV. International Journal of Molecular Sciences. 26(17). 8165–8165.
3.
Vázquez, María J., Laura L. Wilkinson, & Tom Pembroke. (2025). Emotional eating and metabolic dysfunction-associated steatotic liver disease (MASLD): a pre-registered study in a clinical population. Physiology & Behavior. 305. 115186–115186.
6.
Pembroke, Tom, Gareth John, Marek Czajkowski, et al.. (2023). Rising incidence, progression and changing patterns of liver disease in Wales 1999-2019. World Journal of Hepatology. 15(1). 89–106. 4 indexed citations
7.
Pembroke, Tom, Kelly L. Miners, David A. Price, et al.. (2019). Rituximab depletion of intrahepatic B cells to control refractory hepatic autoimmune overlap syndrome. QJM. 112(10). 793–795. 3 indexed citations
8.
Malagoli, Andrea, Maria Osikowicz, Tom Pembroke, et al.. (2019). SAT-286-Application of guidelines for fatty liver in two prospective cohorts of human immunodeficiency virus positive patients. Journal of Hepatology. 70(1). e762–e762. 1 indexed citations
9.
Benmassaoud, Amine, Roy Nitulescu, Tom Pembroke, et al.. (2018). Liver-related Events in Human Immunodeficiency Virus–infected Persons With Occult Cirrhosis. Clinical Infectious Diseases. 69(8). 1422–1430. 13 indexed citations
10.
Scurr, Martin, Tom Pembroke, Anja Bloom, et al.. (2017). Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer. Clinical Cancer Research. 23(22). 6771–6780. 119 indexed citations
11.
Pembroke, Tom, Marc Deschênes, Bertrand Lebouché, et al.. (2017). Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis. Journal of Hepatology. 67(4). 801–808. 70 indexed citations
12.
Pembroke, Tom, et al.. (2016). Fibrofatty Band-Associated Small Bowel Obstruction After Marathon Running. ACG Case Reports Journal. 3(1). e145–e145. 1 indexed citations
14.
Pembroke, Tom, Awen Gallimore, & Andrew Godkin. (2015). Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liver. Journal of Immunological Methods. 424. 131–135. 13 indexed citations
15.
Scurr, Martin, Anja Bloom, Tom Pembroke, et al.. (2013). Escalating Regulation of 5T4-Specific IFN-γ+ CD4+ T Cells Distinguishes Colorectal Cancer Patients from Healthy Controls and Provides a Target for In Vivo Therapy. Cancer Immunology Research. 1(6). 416–425. 15 indexed citations
16.
Pembroke, Tom, Adam Christian, Emma Jones, et al.. (2013). The paradox of NKp46 + natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment. Gut. 63(3). 515–524. 50 indexed citations
17.
Pembroke, Tom, Ian Rees, Kathleen Gallagher, et al.. (2012). Rapid early innate control of hepatitis C virus during IFN‐α treatment compromises adaptive CD4+T‐cell immunity. European Journal of Immunology. 42(9). 2383–2394. 10 indexed citations
18.
Pembroke, Tom, Awen Gallimore, & Andrew Godkin. (2012). Rapid innate control of antigen abrogates adaptive immunity. Immunology. 138(4). 293–297. 2 indexed citations
19.
Pembroke, Tom, et al.. (2011). Reduced NK cell cytotoxicity in hepatitis C infection is associated with reduced levels of cytotoxicity markers NKP30 and NKP46. Gut. 60(Suppl 1). A243.3–A244. 1 indexed citations
20.
Pembroke, Tom, et al.. (2006). Psychological distress and chronic obstructive pulmonary disease in the Renfrew and Paisley (MIDSPAN) study. Journal of Epidemiology & Community Health. 60(9). 789–792. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026